Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

IDEXX Laboratories, Inc. IDXX

Healthcare  —  Diagnostics & Research
519.26 5.87 1.14% as of 25 Sep
Market cap
$40.2B
P/E
36.2×
S&P 500 Member Cash Flow Champion (3y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio 36.74 41.01 51.33 50.27

+8 more quarters
P/S ratio 9.13 10.07 12.64 12.28
P/FCF ratio 33.60 42.30 56.88 59.28
P/Operating CF 119.73 168.09 152.94 127.19
P/B ratio 25.78 28.76 33.89 32.78
Price to Tangible BV 37.67 43.06 50.31 49.55
EV/Sales 9.18 10.12 12.71 12.36
EV/EBITDA 25.93 28.94 36.33 35.60
EV/Operating CF 30.49 37.19 46.27 47.32
EV/FCF 33.80 42.53 57.16 59.65
Quick Ratio 0.64 0.62 0.64 0.62
Current Ratio 1.17 1.12 1.23 1.18
Net Debt/EBITDA 0.54 0.62 0.76 0.81
Debt/Assets 13.07% 13.29% 13.42% 15.50%
Debt/Equity 0.28 0.29 0.28 0.34
Asset Turnover 1.34 1.35 1.30 1.24
Operating CF/Net income 1.03 0.96 1.43 1.47
Capex/Depreciation (0.65) (0.90) (0.77) (1.21)
Interest Coverage 0.00 0.00 0.00 0.00
Research and Development Expense of Revenue 5.38% 5.77% 6.13% 5.74%
Selling, General and Administrative Expense of Revenue 23.68% 25.80% 25.28% 23.99%
Intangible Assets out of Total Assets 0.15 0.15 0.16 0.16
Share Based Compensation of Revenue 1.32% 1.43% 1.48% 1.31%
Graham Net Nets (0.01) (0.01) (0.01) (0.01)
Graham Number 81.15 77.60 76.94 74.66
Earnings Yield 2.72% 2.44% 1.95% 1.99%
Free Cash Flow Yield 2.98% 2.36% 1.76% 1.69%
Revenue per Share 15.41 14.32 13.56 13.80
Operating CF per Share 4.40 3.34 4.42 5.02
Capex per Share (0.34) (0.42) (0.37) (0.56)
Free Cash Flow per Share 4.06 2.92 4.05 4.47
Cash per Share 2.49 2.52 2.24 2.60
Shareholders Equity per Share 20.42 19.54 19.96 19.49
Interest Debt per Share 0.00 0.00 0.00 0.00
Book value per Share 20.42 19.54 19.96 19.49
Free Cash Flow 320.62 232.46 326.13 357.88
Working Capital 221.82 154.22 265.01 225.24
Capital Expenditures (26.54) (33.78) (29.63) (44.46)
Net Current Asset Value (320.27) (375.32) (331.55) (348.47)
EV/EBIT 28.67 32.01 40.21 39.42
Capex to Sales 0.02 0.03 0.03 0.04
Net Profit Margin 27.82% 24.41% 22.76% 24.85%
Price to Operating Income 28.50 31.83 40.01 39.18
Other line items
Average Receivables 593.82 565.50 512.98 539.07
Average Payables 122.84 125.04 112.31 116.43
Average Inventory 392.08 389.19 379.82 390.68
Average Assets 3,386.56 3,299.59 3,322.10 3,368.74
Average Common Equity 1,535.70 1,502.06 1,600.35 1,589.62

Fold the line items

Columns are period end dates